Effects of the porcupine inhibitor, LGK974, on RNF43 mutant and wild type colorectal cancer cell lines

被引：0
|
作者：
Bond, C. [1 ]
Kalimutho, M. [2 ]
Bettington, M. [1 ,3 ,4 ]
Pearson, S. [1 ]
Leggett, B. [1 ,4 ,5 ]
Whitehall, V. [1 ,4 ,6 ]
机构：
[1] QIMR Berghofer Med Res Inst, Conjoint Gastroenterol Lab, Brisbane, Qld, Australia
[2] QIMR Berghofer Med Res Inst, Signal Transduct Lab, Brisbane, Qld, Australia
[3] Envoi Specialist Pathologists, Brisbane, Qld, Australia
[4] Univ Queensland, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[6] Pathol Queensland, Brisbane, Qld, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [31] Low-dose fractionated radiation potentiates the effects of paclitaxel in wild-type and mutant p53 head and neck tumor cell lines
    Dey, S
    Spring, PM
    Arnold, S
    Valentino, J
    Chendil, D
    Regine, WF
    Mohiuddin, M
    Ahmed, MM
    CLINICAL CANCER RESEARCH, 2003, 9 (04) : 1557 - 1565
  • [32] Effects of wild-type p53 gene transfection and 5-FU administration on cell death in colon cancer cell lines
    Oh, ST
    Kim, HJ
    Kang, WK
    Chang, SK
    DISEASES OF THE COLON & RECTUM, 2004, 47 (06) : 1057 - 1058
  • [33] Diverse effects of diazepam on proliferation and etoposide-induced cytotoxicity in two glioma cell lines: expressing wild-type or mutant p53
    Sarissky, M.
    Lavicka, J.
    Sulla, I.
    Radvakova, I.
    Mirossay, A.
    Mojzis, J.
    Mirossay, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 145 - 145
  • [34] Activation of death receptor, DR5 and mitochondria-mediated apoptosis by a 3,4,5-trimethoxybenzyloxy derivative in wild-type and p53 mutant colorectal cancer cell lines
    Zachariah Chee Ken Chan
    Kok Hoong Leong
    Huda Salah Kareem
    Anwar Norazit
    Suzita Mohd Noor
    Azhar Ariffin
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2020, 393 : 405 - 417
  • [35] Activation of death receptor, DR5 and mitochondria-mediated apoptosis by a 3,4,5-trimethoxybenzyloxy derivative in wild-type and p53 mutant colorectal cancer cell lines
    Chan, Zachariah Chee Ken
    Leong, Kok Hoong
    Kareem, Huda Salah
    Norazit, Anwar
    Noor, Suzita Mohd
    Ariffin, Azhar
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (03) : 405 - 417
  • [36] Effects of wild-type p53 expression on the quantity and activity of topoisomerase IIα and β in various human cancer cell lines
    Hochhauser, D
    Valkov, NI
    Gump, JL
    Wei, I
    O'Hare, C
    Hartley, J
    Fan, JG
    Bertino, JR
    Banerjee, D
    Sullivan, DM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1999, 75 (02) : 245 - 257
  • [37] Characterizing the landscape of RING-type E3 ubiquitin transferase-altered (RNF43 alt) colorectal cancer (CRC) and defining unique subsets with potential therapeutic vulnerabilities in microsatellite instability-high (MSI-H) CRC.
    Naqash, Abdul Rafeh
    Nassar, Amin
    Macera, Lisa
    Mauer, Elizabeth
    Guinney, Justin
    Chao, Calvin Y.
    Adib, Elio
    Petricoin, Emanuel
    Mittra, Arjun
    Takebe, Naoko
    Cannon, Timothy Lewis
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Differential effects of the isoflavone genistein on androgen receptor expression and cell proliferation comparing prostate cancer cells with mutant and wild type androgen receptor
    Mahmoud, Abeer M.
    Martin, Iman K.
    Schlicht, Michael J.
    Nonn, Larisa
    Bosland, Maarten C.
    CANCER RESEARCH, 2011, 71
  • [39] ADP-ribosylome analysis reveals homogeneous DNA-damage-induced serine ADP-ribosylation across wild-type and BRCA-mutant breast cancer cell lines (vol 43, 114603, 2024)
    Anagho, Holda Awah
    Mullari, Meeli
    Prosz, Aurel Gyorgy
    Buch-Larsen, Sara Charlotte
    Cho, Hayoung
    Locard-Paulet, Marie
    Szallasi, Zoltan
    Nielsen, Michael Lund
    CELL REPORTS, 2024, 43 (08):
  • [40] Potent anticancer activity against both BRAF-mutant and BRAF wild-type melanoma cell lines using a novel CRM1 nuclear export inhibitor
    Fragomeni, Roberto A. Salas
    Chung, Hye-Won
    Shacham, Sharon
    Kauffman, Michael
    Cusack, James C.
    CANCER RESEARCH, 2012, 72
12345